Statistics from Altmetric.com
Commentary on: OpenUrl
Artemisinin-based combination therapies (ACTs) are the treatment of choice for uncomplicated Plasmodium falciparum malaria in malaria endemic countries. ACT resistance has already been documented in the main, but not solely in Asia,1 therefore therapeutic alternatives should be investigated. As there are no new drugs at advance stages in the pipeline, current focus should be on novel combinations of existing drugs. This prospective randomised study compares the effectiveness of three antimalaria combination drugs—two well-established combination drugs (artesunate-amodiaquine (AA) and atovaquone-proguanil (AP)) and one …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.